Perfil
Nick Yeo is currently the Chief Operating Officer at Veryan Medical Ltd.
He previously worked as a Director at Touchstone Innovations Ltd.
and as a Principal at Ernco 200 LTD.
Cargos activos de Nick Yeo
Empresas | Cargo | Inicio |
---|---|---|
Veryan Medical Ltd.
Veryan Medical Ltd. BiotechnologyHealth Technology Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom. | Director de Operaciones | - |
Antiguos cargos conocidos de Nick Yeo.
Empresas | Cargo | Fin |
---|---|---|
Ernco 200 LTD
Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Ernco 200 LTD manufactured pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy. The company was headquartered in Stirling, the United Kingdom. | Corporate Officer/Principal | - |
TOUCHSTONE INNOVATIONS PLC | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Touchstone Innovations Ltd.
Touchstone Innovations Ltd. Investment ManagersFinance Touchstone Innovations Ltd. engages in the provision of technology and commercialization services. The company was founded by Susan Jane Searle in 1986 and is headquartered in London, the United Kingdom. | Finance |
Ernco 200 LTD
Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Ernco 200 LTD manufactured pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy. The company was headquartered in Stirling, the United Kingdom. | Health Technology |
Veryan Medical Ltd.
Veryan Medical Ltd. BiotechnologyHealth Technology Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Nick Yeo